Apis Capital Advisors’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History
Bought
Maintained
Sold
Apis Capital Advisors's ASPX Position: Q2 2015 in Review
Apis Capital Advisors sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 69,460 shares — an estimated $5.46M sold.
Apis Capital Advisors first reported a position in ASPX in Q4 2014 and held it in 2 quarters. The position peaked at $5.46M in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.
- Apis Capital Advisors reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
- Apis Capital Advisors sold 69,460 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $5.46M.
- Apis Capital Advisors first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q4 2014 and held it in 2 quarters.
- Apis Capital Advisors's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $5.46M in Q1 2015.
- 0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.
Based on Apis Capital Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.